Daily aspirin reduces risk of ovarian cancer, regardless of genetics

Published Date: 08 Mar 2023

New findings show that frequent aspirin use provides protection against ovarian cancer, regardless of a person's genetic risk.

Read Full News

Latest News

Menstruation topic still stigmatized by younger generation in Spain, study finds

The menstrual taboo persists. This is the main conclusion of a pioneering macro-study in Spain involving more than 4,000 participants and led by the INGENIO Institute, a joint center of the Spanish National Research Council ...

Research team develops actionable tool to assess risk for premature births

Researchers at NYU and partners within the International Healthy Outcomes of Pregnancy for Everyone (HOPE) Consortium have developed a novel tool, the Preterm Birth Actionable Risk Index (PTB-ARIx), designed to identify pregnant ...

AHA: Study examines impact of adequate prenatal care for congenital heart disease

For cases of mild congenital heart defects (CHDs), more prenatal visits are associated with lower probability of delivery at a cardiac center, according to a study published online Nov. 9 in JAMA Network Open to coincide ...

Severe nausea during pregnancy and depression: Study reveals bidirectional association

A recent study conducted at the University of Turku in Finland showed that hyperemesis gravidarum, a severe form of nausea that occurs during pregnancy, is linked to depression. Women who experienced severe nausea were more ...

Common cesarean closure method linked to long-term complications, experts suggest change

The most common technique used for closing the uterus after a cesarean delivery causes so many long-term complications that it's time to question its use. That's the conclusion reached by two world-renowned specialists in ...

From post-partum depression to relationship woes: The importance of mental health after giving birth

"Postpartum depression" has been discussed as an identifiable, measurable, treatable disorder for 50 years now. Thresholds, scales, prevalence rates: everything seems clear, even reassuring.

Todays Updates

FDA Grants Priority Review to Efgartigimod, First Potential Therapy for Seronegative Myasthenia Gravis Victoria Johnson

argenx's efgartigimod-alfa therapy was approved for seropositive generalized myasthenia gravis in 2021.

Early Opicapone Initiation in Parkinson Leads to Continued Long-Term Therapeutic Benefits Marco Meglio

Early initiation of opicapone significantly reduces OFF time and enhances ON time in patients with recently diagnosed Parkinson's disease, improving overall treatment outcomes.

FDA Requests HOPE-3 Clinical Study Report for Deramiocel BLA in DMD Cardiomyopathy Isabella Ciccone, MPH

The FDA requested the full data from the phase 3 HOPE-3 study as part of its review of the biologics license application for deramiocel, which Capricor plans to submit in February 2026.

Low-Dose Opioids Show Long-Term Dose Stability, Effectiveness in Augmented Restless Legs Syndrome Louie Pasculli

A five-year analysis from the National RLS Opioid Registry found that most patients with dopamine agonist augmented restless legs syndrome maintained stable, low-dose opioid therapy with sustained symptom control.

Personalized Care Improvements Identified for Older Patients with Skin Cancer

Personalized Care Improvements Identified for Older Patients with Skin Cancer

New Findings on Acne Incidence in Transgender Individuals, With Howa Yeung, MD, MSc

New Findings on Acne Incidence in Transgender Individuals, With Howa Yeung, MD, MSc

What to Expect at the 2026 Maui Derm Conference

What to Expect at the 2026 Maui Derm Conference

Todays Updates

FDA Grants Priority Review to Efgartigimod, First Potential Therapy for Seronegative Myasthenia Gravis Victoria Johnson

argenx's efgartigimod-alfa therapy was approved for seropositive generalized myasthenia gravis in 2021.

Early Opicapone Initiation in Parkinson Leads to Continued Long-Term Therapeutic Benefits Marco Meglio

Early initiation of opicapone significantly reduces OFF time and enhances ON time in patients with recently diagnosed Parkinson's disease, improving overall treatment outcomes.

FDA Requests HOPE-3 Clinical Study Report for Deramiocel BLA in DMD Cardiomyopathy Isabella Ciccone, MPH

The FDA requested the full data from the phase 3 HOPE-3 study as part of its review of the biologics license application for deramiocel, which Capricor plans to submit in February 2026.

Low-Dose Opioids Show Long-Term Dose Stability, Effectiveness in Augmented Restless Legs Syndrome Louie Pasculli

A five-year analysis from the National RLS Opioid Registry found that most patients with dopamine agonist augmented restless legs syndrome maintained stable, low-dose opioid therapy with sustained symptom control.

Personalized Care Improvements Identified for Older Patients with Skin Cancer

Personalized Care Improvements Identified for Older Patients with Skin Cancer

New Findings on Acne Incidence in Transgender Individuals, With Howa Yeung, MD, MSc

New Findings on Acne Incidence in Transgender Individuals, With Howa Yeung, MD, MSc

What to Expect at the 2026 Maui Derm Conference

What to Expect at the 2026 Maui Derm Conference

Latest News

The menstrual taboo persists. This is the main conclusion of a pioneering macro-study in Spain involving more than 4,000 participants and led by the INGENIO Institute, a joint center of the Spanish National Research Council ...

Researchers at NYU and partners within the International Healthy Outcomes of Pregnancy for Everyone (HOPE) Consortium have developed a novel tool, the Preterm Birth Actionable Risk Index (PTB-ARIx), designed to identify pregnant ...

For cases of mild congenital heart defects (CHDs), more prenatal visits are associated with lower probability of delivery at a cardiac center, according to a study published online Nov. 9 in JAMA Network Open to coincide ...

A recent study conducted at the University of Turku in Finland showed that hyperemesis gravidarum, a severe form of nausea that occurs during pregnancy, is linked to depression. Women who experienced severe nausea were more ...

The most common technique used for closing the uterus after a cesarean delivery causes so many long-term complications that it's time to question its use. That's the conclusion reached by two world-renowned specialists in ...

"Postpartum depression" has been discussed as an identifiable, measurable, treatable disorder for 50 years now. Thresholds, scales, prevalence rates: everything seems clear, even reassuring.

News All Time

New study shows long-term effectiveness of HPV vaccine

A new study has confirmed that the human papillomavirus (HPV) vaccine provides strong and sustained protection against cervical disease that can develop into cancer.

Exercise reduces risk of common postpartum pelvic floor problems

Targeted pelvic floor muscle training in the first year postpartum significantly reduces the risk of two common pelvic floor disorders, according to a study that rewrites the longstanding narrative that these disorders are ...

Problems with regulating emotions during pregnancy may help predict perinatal depression

Around 1 in 5 mothers experience perinatal depression. This condition involves depressive episodes during pregnancy or just after birth—often with lasting effects on both mother and child.

Sugar–protein interactions, critical for placenta during early pregnancy, shed light on common complications

During the first weeks of pregnancy, the developing placenta in a mother's womb undergoes a dramatic change. Individual cells merge, forming a continuous barrier that will spend the next nine months ferrying oxygen and nutrients ...

The quiet collapse of America's reproductive health safety net

In late October, Maine Family Planning announced three rural clinics in northern Maine would close by month's end. These primary care and reproductive health clinics served about 800 patients, many uninsured or on Medicaid.

Meta-analysis evaluates effectiveness of various psychological therapies for perinatal depression

A systematic review and meta-analysis evaluated the effectiveness of psychological therapies for perinatal depression, the most prevalent maternal mental health disorder. The review, published in the Annals of Internal Medicine, ...

Wildfire smoke exposure during pregnancy linked to higher risk of preterm birth

About 10% of American babies are born prematurely. Birth before 37 weeks can lead to a cascade of health risks, both immediate and long-term, making prevention a vital tool for improving public health over generations.

Back pain during pregnancy is often dismissed as a passing discomfort—a nurse explains why it should be taken seriously

About half to three-quarters of expectant mothers experience pain during pregnancy that is largely untreated, contributing to preventable suffering and harm. Many mothers avoid medications and treatments during pregnancy ...

Researchers discuss gaps, obstacles and solutions for contraception

Contraception and family planning are vital aspects of sexual and reproductive health and rights. Despite major advances in modern contraception over the past 60 years, many gaps remain and the rate of unplanned pregnancies ...

COVID-19 during pregnancy linked to higher risk of neurodevelopmental disorders in children

Children born to mothers who had COVID-19 while pregnant face an elevated risk of developmental disorders by the time they turn 3 years old, including speech delays, autism, motor disorders, and other developmental delays, ...

Safeguarding fertility: Study investigates key hormone for women with cancer choosing fertility preservation

Newly diagnosed female cancer patients of reproductive age have a very short window for storing their eggs and embryos before starting cancer treatment. This is a process known as fertility preservation (FP), which protects ...

Breast cancer risk varies between different hormonal contraceptives, research reveals

Some common hormonal contraceptives are linked to a slightly higher risk of breast cancer than others. This is shown by a Swedish study from Uppsala University, in which researchers followed more than two million women and ...

Punitive drug laws may deter prenatal care and hospital-based delivery

States that explicitly criminalize prenatal drug use may unintentionally discourage pregnant people from seeking essential medical care, according to new research from Columbia University Mailman School of Public Health. ...

Highlighting key therapies that support women through high-risk pregnancies 

Joint research from Edith Cowan University (ECU) and the University of St. Augustine for Health Sciences, in the US, is shedding new light on the broader potential of psychosocial occupational therapy, revealing it can play ...

Study shows Australian preterm birth prevention program is working

New data has shown that an initiative to reduce preterm births in Australia has led to a significant decrease in rates of potentially harmful early birth and improved pregnancy outcomes for women across the country.

Vitamin D deficiency increases risk of complicated deliveries, finds study

A research team at Uppsala University has identified a clear link between osteomalacia—a form of bone softening commonly caused by vitamin D deficiency—and a fivefold increased risk of emergency cesarean sections or the ...

Recommended News For You

Colon cancer and exercise: Can physical activity reprogram genes?

Genetics and therapy type determine second cancer risk after childhood treatment, study finds

Adding Isatuximab to Standard Backbone Prolongs PFS in Myeloma

Immunotherapy-TACE Regimen Boosts PFS in Unresectable Liver Cancer

examining differences in the rates of breast reconstruction following mastectomies.

Mammo Responsibility Increases Screening; Opioids for Pain Related to Cancer? Ignored CRC Signs.

Potentially Novel Approach for Treating Advanced Colorectal Cancer with KRAS Mutations.

Recommended Articles For You

The Predictive Power of Theranostics in Palliative Neuroendocrine Tumor Management 

Precision Era in Pediatric Oncology, from Genomic Breakthroughs to Lifelong Learning 

Understanding Axitinib: What You Need To Know For Your Treatment Plan 

From Bruises to Blood Clots: Everything You Need to Know about Hematoma  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

If CD19 CAR T-Cell Therapy Fails in Lymphoma, Try a CD22 Version

2.

Psychedelic Therapy Tied to Reduced Depression, Anxiety.

3.

Early-life exposure to air and light pollution linked to increased risk of pediatric thyroid cancer

4.

Survival is extended by a new treatment option for metastatic colorectal cancer.

5.

Immunotherapy Is As Safe As Other Cancer Treatments During Pregnancy.

1.

Imaging in Peritoneal Neoplasms: Diagnostic Advances and Multimodal Treatment Strategies

2.

Advancements in Cancer Treatment Strategies for Non-Hodgkin Lymphoma

3.

Oncolytic Adenoviruses Targeting PD-L1: Advancing Cancer Immunotherapy and Tumor Control

4.

The Unfolding Revolution of Precision Medicine, Immunotherapy, and Digital Transformation in Medical Oncology 2025

5.

KEYNOTE-826: Optimizing Outcomes in Persistent, Recurrent, or Metastatic Cervical Cancer

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma

2.

Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases

3.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I

4.

Managing CNS diseases at the point of diagnosis in ALK + NSCLC

5.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot